10hon MSNOpinion
A new Medicare program that uses AI for prior authorizations is hurting patients and delaying care
Six states are part of a pilot program by CMS to reduce “waste, fraud and abuse.” ...
Key Takeaways A temporary Medicare program to cover GLP-1 drugs for obesity has been extendedThe program allows eligible ...
The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity ...
This story is part of a Seattle Times focus on the affordability crisis in the Northwest. We explore the high cost of living ...
Authorities said they’ve arrested a couple accused of defrauding Louisiana’s Medicaid program by nearly $135,000.
The Centers for Medicare and Medicaid Services (CMS) and the U.S. Food and Drug Administration (FDA) announced on Thursday ...
The Trump administration decided to put the pilot on hold until at least 2027.
Medicare delayed a plan to make insurance companies cover GLP-1 drugs Wegovy and Zepbound. Instead, Medicare will cover the ...
The BALANCE program was intended to cover weight-loss drugs for Medicaid beneficiaries, but is delayed. A new solution with ...
Without big Medicare insurers, the future of program to cover popular obesity drugs had been in question.
NEW YORK (AP) — The Trump administration will require all 50 states to explain their plans to revalidate some of their ...
Charlotte‑Mecklenburg Schools is considering major changes to its magnet programs, including a proposal to merge two of the district’s most rigorous academic pathways.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results